English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    R. P. Tkachenko, N. Yu. Kondratyuk, O. G. Kuryk, O. M. Mostiuk, L. A. Cherkasova, K. V. Bazdyrev, O. L. Kisilenko


    About the author: R. P. Tkachenko, N. Yu. Kondratyuk, O. G. Kuryk, O. M. Mostiuk, L. A. Cherkasova, K. V. Bazdyrev, O. L. Kisilenko
    Type of article Scentific article
    Annotation Secondary hyperparathyroidism develops in patients with chronic kidney disease due to stimulation of the thyroid gland with the emergence of autonomy of their function, which causes metastatic calcification and calciphylaxis. If conservative treatment of this pathology is ineffective, subtotal parathyroidectomy is performed. The purpose of the study was to compare the results of surgical and conservative treatment of patients with secondary hyperparathyroidism with calcification and calciphylaxis. Patients with medical treatment had complaints of pain in the bones and joints, itchy skin, convulsions, while in patients after surgery the symptoms had a clear tendency to decrease. There was the healing of trophic ulcers of the skin, a decrease in the size of calcifications in 2–3 months and their disappearance in a year after parathyroidectomy. Parathyroid hormone levels dropped to normal within a few days after surgery, and calcium and phosphorus levels dropped to safe levels. Therefore, surgery is an effective treatment for patients with chronic kidney disease, as it quickly normalizes laboratory parameters, eliminates clinical manifestations, reduces the manifestations of metastatic soft tissue calcification and intravascular deposition of calcium salts.
    Tags secondary hyperparathyroidism, metastatic calcification, calciphylaxis, chronic kidney disease, subtotal parathyroidectomy
    • Tkachenko RP, Kurik OG, GolovkoAS. Khіrurgіchne lіkuvannya vtorynnoho gіperparatyreozu u patsіentіv z khronіchnoyu khvoroboyu nyrok. Klіnіchna khіrurgіya. 2018; 85(5), 47–50. https://doi.org/10.26779/2522-1396.2018.05.47 [in Ukrainian]
    • Abdalla AO, Al-Khafaji J, Taha M, Malik S. A Fatal Case of Non-Uremic Calciphylaxis: A Case Report and Literature Review.Am J Case Rep. 2018 Jul 9; 19:804–807. doi: 10.12659/AJCR.909546.
    • Chiriac A, Grosu OM, Terinte C, Perţea M. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment. J Dermatolog Treat. 2020 Aug; 31(5):545–548. doi: 10.1080/09546634.2019.1618435. Epub 2019 May 31.PMID: 31075991
    • Cocchiara G, Fazzotta S, Palumbo VD, Damiano G, Cajozzo M, Maione C. et al. The medical and surgical treatment in secondary and tertiary hyperparathyroidism. Review Clin Ter. 2017 Mar-Apr; 168(2):e158-e167. doi: 10.7417/CT.2017.1999.
    • Ellis CL, O'Neill WC. Questionable specificity of histologic findings in calcific uremic arteriolopathy.Kidney Int. 2018 Aug; 94(2):390–395. doi: 10.1016/j.kint.2018.03.016. Epub 2018 Jun 7. PMID: 29885932.
    • Gaisne R, Péré M, Menoyo V, Hourmant M, Larmet-Burgeot D. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.BMC Nephrol. 2020 Feb 26; 21(1):63. doi: 10.1186/s12882-020-01722-y. PMID: 32101140.
    • Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.Circulation. 2021 Mar 16;143(11):1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.PMID: 33720773
    • Kim JS, Hwang HS. Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication. Korean Circ J. 2021 Dec; 51(12):961–982. doi: 10.4070/kcj.2021.0995.PMID: 34854578
    • Kim MS, Kim GH, Lee CH, Park JS, Lee JY, Tae K. Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism. Clinical and Experimental Otorhinolaryngology. 2020 Feb 21; 13(2): 173–178. doi: 10.21053/ceo.2019.01340. PMID: 3207536.
    • Konturek A, Barczynski M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg. 2016 Nov; 401(7):965–74. doi: 10.1007/s00423-016-1447-7. PMID: 27233241
    • Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018 Jun; 13(6):952–61. PMID: 29523679 PMCID: PMC5989682 DOI: 10.2215/CJN.10390917.
    • Nigwekar SU, Sprague SM. We Do Too Many Parathyroidectomies for Calciphylaxis. Semin Dial. 2016 Jul;29(4):312–4. PMID: 27082830 DOI: 10.1111/sdi.12502
    • Ruderman I, Hewitson TD, Smith ER, Holt SG, Wigg B, ToussaintND. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease. BMC Nephrol. 2020 Jul 16; 21(1):279. doi: 10.1186/s12882-020-01928-0. PMID: 32677907.
    • Starchenko II, Grinko RM, Shkodina AD, Filenko BM, Vynnyk NI, Roiko NV, et al. The Degree of Pineal Gland Calcification in the Aged People is Associated with Changes in the Internal Structure. Journal of International Dental and Medical Research. 2021; 14(2):841–44. http://www.jidmr.com
    • Won HR, Koo BS. Recent Trends in the Surgical Treatment of Secondary Hyperparathyroidism. Clinical and Experimental Otorhinolaryngology. 2020 May 1; 13(2): 91–92. doi: 10.21053/ceo.2020.00493.
    Publication of the article «World of Medicine and Biology» №1(79), 2022 year, 147-151 pages, index UDK 616 - 008.9 – 06:616.381 – 005.4 – 091.8
    DOI 10.26724/2079-8334-2022-1-79-147-151